Introduction {#sec1-1}
============

Leprosy, the age-old disease described as early as 600 BC\[[@ref1]\] in Susruth Samhita, still remains one of the most ostracized diseases due to its resultant physical deformity and social stigmatization associated with it. India has always been a country with the highest number of patients with leprosy in the world. The physical deformities due to no treatment or delayed treatment cause psychological and social disabilities. These disabilities can lead to social stigmatization, resulting in isolation of the patient from the society and a decrease in the quality of life (QoL).\[[@ref2]\] Multidrug therapy has been very effective in the past few decades and the patients have benefitted greatly. However, often the effects of the disease linger on indefinitely due to the residual permanent impairments.\[[@ref3]\] Considerable efforts have been made to reduce the development of disability in patients with leprosy. Still there are a large number of cured patients with residual deformities.\[[@ref4]\] These deformities can have a negative impact on the QoL of patients with leprosy and even on those who have been cured of the infection.\[[@ref5]\]

World Health Organization has defined QoL as the "individual\'s perception of their position in the context of culture and value systems in which they live and in relation to their goals, expectations, standards and concerns."\[[@ref6]\] The concept of QoL includes physical activity, psychological condition, degree of independence, and social relationship.\[[@ref7]\] The QoL in leprosy can be affected by various factors including the onset and duration of disease, social factors, clinical factors such as nerve involvement, systemic features, deformity, disability grade, and type of leprosy. Stigma toward persons affected by leprosy and their families can also adversely affect their QoL due to its impact on their mobility, interpersonal relationship, marriage, employment, leisure, and social activity.\[[@ref8]\]

A lot of people of our country are adversely affected by poverty, illiteracy, and unhygienic living conditions. The additional burden of the disease is likely to reduce their QoL further. Contrarily, people living under such adverse conditions may not perceive the disease to cause much change in their QoL.

There are several studies of QoL assessment of patients with leprosy from Africa, South America, and parts of Asia.\[[@ref9][@ref10][@ref11][@ref12][@ref13]\] However, similar studies of good quality have not been done from eastern India. Hence, the study was conducted to assess the QoL of patients with leprosy in our population. Moreover, the assessment of QoL of patients with leprosy is also very important for successful implementation of any rehabilitation program.

The primary objective of this study was to assess the QoL of patients with leprosy in this region using Dermatology Life Quality Index (DLQI)\[[@ref14]\] as a tool.

The secondary objectives were to assess how demographic profile of these patients affects QoL, whether clinical classification of leprosy has any bearing on QoL, and to assess whether clinical aspects of the disease such as presence of patches, systemic features, nerve involvement, deformity, and disability grade have an impact on it.

Materials and Methods {#sec1-2}
=====================

The study was conducted in the Department of Dermatology, Institute of Post Graduate Medical Education and Research, Kolkata, India. Cases were recorded over a period of 2 years from 2016 to 2017. We included 114 patients in our study.

All patients presenting with cardinal signs of leprosy and willing to participate in the study through a written informed consent were included in the study. Patients with leprosy with any other debilitating disease, psychiatric problem, and other medical conditions which may have an impact on QoL were excluded from the study.

We have used DLQI\[[@ref14]\] which had been validated in Hindi, English, and Bengali as the tool for assessing the QoL in patients with leprosy. The questionnaire was applied to each patient individually by the same investigator. DLQI,\[[@ref14]\] developed by Professor A Y Finlay and colleagues, is one of the most used instruments for assessing dermatology specific QoL. It is a simple 10 questions validated questionnaire that has been used in over 40 different skin conditions in over 80 countries and is available in over 90 languages. Each question has 3 marks. The DLQI is calculated by summing the score of each question resulting in a maximum of 30 and a minimum of 0. The higher the score is, the more the QoL is impaired. The DLQI can also be expressed as a percentage of maximum score \[[Figure 1](#F1){ref-type="fig"}\].

![Dermatology Life Quality Index questionnaire](IJD-65-42-g001){#F1}

Patients attending dermatology outpatients department were screened for leprosy. Written informed consent was taken from the patients. History and clinical examination findings were recorded in a case record form. Then patients were requested to answer the questions of the DLQI questionnaire after clearly explaining them the questions in their preferred language. DLQI scores were calculated. DLQI scores were compared and evaluated at the end of the study.

This is a questionnaire-based descriptive study. All clinical data were recorded at first visit.

Data were analyzed by appropriate statistical tests using statistical software, Statistica version 26.0 (IBM Corporation, Armonk, NY, USA).

Results {#sec1-3}
=======

Among a total of 114 patients, leprosy had no impact on the QoL of 15 (13.16%) patients. There was a mild impact in 23 (20.18%) of the patients. There was moderate impact in 37 (32.46%) of the patients. The disease had severe impact in the QoL of 39 (34.21%) patients. None of the patients had very severe impact.

In total, there were 88 male patients and 26 female patients. Leprosy had no effect in the QoL of 13 (14.77%) of the male patients. There was a mild impact in 23 (26.14%), moderate impact in 24 (27.27%), and severe impact in the QoL of 28 (24.56%) of the male patients. Leprosy had no impact in the QoL of two (7.69%) of the female patients. There was moderate effect in 13 (50%) of the female patients. The disease had severe impact in the QoL of 11 (42.30%) of the female patients \[[Table 1](#T1){ref-type="table"}\].

###### 

Gender distribution of the impact on QoL

  Effect on QoL            No. (%) of patients (*n* = 114 patients)   No. (%) of males (*n* = 88)   No. (%) of females (*n* = 26)   *P* (between groups)
  ------------------------ ------------------------------------------ ----------------------------- ------------------------------- ----------------------
  No effect                15 (13.16%)                                13 (14.77%)                   2 (7.69%)                       0.615
  Small effect             23 (20.18%)                                23 (26.14%)                   0 (0%)                          0.024
  Moderate effect          37 (32.46%)                                24 (27.27%)                   13 (50%)                        0.203
  Very large effect        39 (34.21%)                                28 (24.56%)                   11 (42.30%)                     0.643
  Extremely large effect   0 (0%)                                     0 (0%)                        0 (0%)                          0

QoL=Quality of life, *P*-value obtained by Chi-square test between male and female patients

The mean DLQI score among the 114 patients was 8.48 ± 5.48. The range of the DLQI score was 0--20. The median score was 8 (3--12). The affection of different aspects of DLQI is depicted in [Table 2](#T2){ref-type="table"}.

###### 

Affection of different aspects of DLQI

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                 Total DLQI score (max 30)   Symptoms and feelings score (max 6)   Daily activities score (max 6)   Leisure score (max 6)   Work and school score (max 3)   Personal relationships score (max 6)   Treatment score (max 3)
  -------------- --------------------------- ------------------------------------- -------------------------------- ----------------------- ------------------------------- -------------------------------------- -------------------------
  Mean±SD\       8.48±5.48\                  2.10±1.53\                            2.21±1.49\                       1.01±1.22\              1.62±1.24\                      0.80±1.11\                             0.80±0.76\
  Range\         0-20\                       0-6\                                  0-5\                             0-5\                    0-3\                            0-4\                                   0-3\
  Median (IQR)   8                           2 (1, 3)                              2 (1, 3)                         1 (0, 2)                2 (0, 3)                        0 (0, 1)                               1 (0, 1)

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

QoL=Quality of life; DLQI=Dermatology Life Quality Index; SD=Standard deviation; IQR=Interquartile range

Among the 114 patients included in the study, the youngest patient was 11 year old and the oldest one was 75 year old. Most of the patients \[32 (28.07%)\] were in the age group of 41--50 years. Fifty (43.86%) patients were from rural areas. About 36 (31.58%) patients were from suburban areas and 28 (24.6%) were from urban areas. A total of 62 (57.82%) patients belonged to low socioeconomic status and 51 (44.74%) belonged to middle socioeconomic status. Only one (0.88%) patient was of high socioeconomic status.

Among the demographic features, gender had an important impact on QoL (*P* \< 0.05). Other demographic factors such as age, habitat, and socioeconomic status had no statistically significant impact on DLQI score \[[Table 3](#T3){ref-type="table"}\].

###### 

Association of demographic features with DLQI score

  Parameter              Correlation co-efficient   95% Confidence Interval   *P*
  ---------------------- -------------------------- ------------------------- -------
  Age                    0.072                      −0.114 to 0.252           0.448
  Gender                 −0.187                     −0.359 to−0.004           0.046
  Residence              −0.128                     −0.305 to 0.057           0.173
  Socioeconomic status   −0.100                     −0.278 to 0.087           0.295
  Marital status         −0.062                     −0.243 to 0.124           0.515

DLQI=Dermatology Life Quality Index; Correlation obtained by Pearson's correlation for age, Spearman's rank correlation for others

A majority of our patients had some form of nerve involvement (81, 71.05%). A substantial number of patients (52, 45.61%) had systemic features. Reaction (Type 1 or Type 2) was present in 51 (44.74%) patients. Patches were present in 102 (89.47%) patients. The presence of patches did not have any statistically significant correlation with DLQI score. Nerve involvement had a positive correlation with DLQI score. Systemic features had a strong positive correlation with DLQI score. Reactions also had a positive correlation with DLQI score. Therefore, the more the presence of nerve involvement, systemic features, and reactions, the more the DLQI score and the more the adverse impact on QoL. The presence of patches did not have much impact on QoL.

Among a total of 114 patients in our study, 37 (32.46%) of the patients had tuberculoid (TT) leprosy, 40 (35.07%) had borderline tuberculoid (BT) leprosy, 6 (5.26%) had borderline (BB) leprosy, 11 (09.65%) had borderline lepromatous (BL) leprosy, 19 (16.67%) had lepromatous (LL) leprosy, and 1 (0.88%) had pure neural (PN) type of leprosy.

The spectrum of leprosy had a statistically significant positive correlation with DLQI score. The DLQI score increased from TT pole towards LL pole. That showed that there was more impairment in the QoL of patients of the LL pole than in patients of the TT pole \[95% Confidence Interval (CI) = 0.103 to 0.443; *P* = 0.002\].

Deformity was present in 44 (38.60%) patients and was absent in 70 (61.40%) patients. Deformity had a positive correlation with DLQI score. Presence of deformities led to higher DLQI score \[95% CI = 0.367 to 0.639; *P* \< 0.0001\] and so has more negative impact on the QoL.

Of the patients with disability, 62 (54.39%) had Grade 1 disability and 44 (38.60%) had Grade 2 disability. Grade of disability had a positive correlation with DLQI score \[95% CI = 0.429 to 0.681; *P* \< 0.0001\]. Therefore, the more the presence of deformity and higher the disability grade, the greater is the DLQI score and the more is the adverse impact on QoL.

Discussion {#sec1-4}
==========

It is believed by all that leprosy has some effects QoL. However, very few studies have tried to detect and assess the actual impact of the disease on the QoL of the patients. It is also unusual that there is hardly any study which has tried to find out factors (demographic or disease-related) which are responsible for the adverse impact on the QoL. A large number of people in India are still affected by leprosy. Keeping this background in mind, we wanted to find out the extent of damage this disease causes in the QoL of a patient. We also wanted to identify some of the demographic and clinical factors which are associated with this adverse effect on QoL.

Most of the patients included in our study had some adverse impact on their QoL because of leprosy. The disease had a very large effect on the QoL of 39 (34.21%) patients. Several other studies have shown that the QoL of the patients has been adversely affected by leprosy.\[[@ref15][@ref16][@ref17]\] In our study, the mean DLQI score was 8.48 ± 5.48, the range was 0--20, and the median was 8 (3--12). The mean DLQI score in a study conducted on patients with leprosy in Brazil by Budel *et al*. was 10.23.\[[@ref18]\]

Our study showed that in leprosy males were more frequent than females. This has been observed in many other studies.\[[@ref19][@ref20]\] It could be because males are exposed to greater chances of infection or because they have more accessibility to healthcare system. We found that QoL of female patients was more affected than male patients. A study conducted by Bello *et al*. also found similar results.\[[@ref21]\]

Majority of the patients, that is, 32 (28.07%), were in the age group of 41--50 years. The mean age of the patients of our study was 38.11 ± 12.16. An epidemiological study was conducted which found that there was a first peak in the age group of 10--14 years followed by depression and then a rise and plateau covering ages 30--60 years.\[[@ref20]\] The DLQI score was higher for patients who were older in general, but there was no strong correlation and it can be said that age of patients with leprosy does not have significant effect on their QoL. Similar results regarding the relationship of age to QoL was shown in a study conducted by Bello *et al*.\[[@ref21]\]

In our study, 62 (57.82%) of the patients belonged to low socioeconomic class. In a study conducted by Kumar *et al*. too, most of the patients belonged to low socioeconomic status.\[[@ref22]\] The possible reason for this increased incidence of the disease in low socioeconomic group may be due to overcrowding, poor hygiene, and increased exposure. However, there was no significant impact of socioeconomic status on QoL.

To the best of our knowledge, no other study before us has tried to find out the clinical factors of leprosy which have effect on QoL. In our study, we found that clinical factors such as systemic features, nerve impairment, reaction, type of leprosy, deformity, and disability grades had significant impact on the QoL of patients with leprosy. Demographic factors such as age, socioeconomic status, and habitat did not have much impact on the QoL. Another interesting point noted in our study is that the presence of patch, which is long considered as a social stigma, has no significant effect on the QoL.

Conclusion {#sec1-5}
==========

Leprosy was long regarded as a social disease. However, there was paucity of data regarding the actual impact of leprosy on QoL. Our study reveals that there is a huge impact of leprosy on the QoL of the patients. Although it is considered a social disease, at least in our part of the country, demographics has minimal effect on the QoL. Rather, important clinical aspects such as systemic features, nerve involvement, reaction, deformity, and disability have profound impact on the QoL of the patients.

Multidrug therapy has been greatly successful to reduce the burden of leprosy in our country. Even then it is largely believed that stigma and social discrimination persist. Our study has clearly revealed that most of the factors which are adversely affecting the QoL in patients with leprosy are preventable. Therefore, it can be concluded that the impact of leprosy on QoL can be reduced greatly if the disease is diagnosed early and treated effectively. Efforts and research must continue for finding out better methods of early detection and effective management of leprosy.
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